The fibrosis and atrial fibrillation: Is the transforming growth factor-β1 a candidate etiology of atrial fibrillation

This publication has 20 references indexed in Scilit:

• Transforming Growth Factor-β, Cell Signaling and Cardiovascular Disorders
  Current Vascular Pharmacology, 2005
• Effect of Angiotensin II Receptor Blocker on Plasma Levels of TGF-β1 and Interstitial Fibrosis in Hypertensive Kidney Transplant Patients
  American Journal of Nephrology, 2003
• Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β₁
  American Journal of Physiology-Heart and Circulatory Physiology, 2002
• Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
  American Journal of Kidney Diseases, 2002
• Induction of Cardiac Fibrosis by Transforming Growth Factor-β1
  Molecular Genetics and Metabolism, 2000
• Angiotensin II directly increases transforming growth factor β1 and osteopontin and indirectly affects collagen mRNA expression in the human heart
  Cardiovascular Research, 2000
• Atrial but Not Ventricular Fibrosis in Mice Expressing a Mutant Transforming Growth Factor-β ₁ Transgene in the Heart
  Circulation Research, 2000
• Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
  New England Journal of Medicine, 1998
• Early Induction of Transforming Growth Factor-β via Angiotensin II Type 1 Receptors Contributes to Cardiac Fibrosis Induced by Long-term Blockade of Nitric Oxide Synthesis in Rats
  Hypertension, 1998
• Evidence for reentry as a mechanism of cardiac arrhythmias
  Published by Springer Nature ,1975